SHPRH Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57190
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to SHPRH(SNF2 histone linker PHD RING helicase) Antibody(against the N terminal of SHPRH.
Peptide sequence SIIPDVLEEDEDDPESEPEGQDIDELYHFVKQTHQQETQSIQVDVQHPAL. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for SHPRH Antibody
Western Blot: SHPRH Antibody [NBP1-57190]
Western Blot: SHPRH Antibody [NBP1-57190] - Hela cell lysate, concentration 0.2-1 ug/ml.Applications for SHPRH Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SHPRH
Alternate Names
2610103K11Rik, bA545I5.2, E3 ubiquitin-protein ligase SHPRH, EC 3.6.4.-, EC 6.3.2.-, FLJ27258, FLJ37625, FLJ90837, histone-linker, PHD and RING finger domain-containing helicase, KIAA2023FLJ45012, MGC134886, SNF2 histone linker PHD RING helicase
Gene Symbol
SHPRH
UniProt
Additional SHPRH Products
Product Documents for SHPRH Antibody
Product Specific Notices for SHPRH Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...